Literature DB >> 29329348

Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.

.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0189410.].

Entities:  

Year:  2018        PMID： 29329348      PMCID： PMC5766248          DOI： 10.1371/journal.pone.0191454

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


The ninth author's name appears incorrectly in the XML of the article. The ninth author's name should be indexed as: van Wijngaarden E. The publisher apologizes for the error.
  1 in total

1.  Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.

Authors:  Eric S Kim; Andrea M Baran; Esther L Mondo; Thomas D Rodgers; Gradon C Nielsen; David W Dougherty; Kishan J Pandya; David Q Rich; Edwin van Wijngaarden
Journal:  PLoS One       Date:  2017-12-11       Impact factor: 3.240
  1 in total
  1 in total

1.  MiR-514 attenuates proliferation and increases chemoresistance by targeting ATP binding cassette subfamily in ovarian cancer.

Authors:  Sha Xiao; Ming Zhang; Chang Liu; Deling Wang
Journal:  Mol Genet Genomics       Date:  2018-05-11       Impact factor: 3.291
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.